A research project led by the Massachusetts Institute of Technology has created an AI that enables you to communicate with the self you will become.
Author: admin (Kendrick Williams)
Post
OPENAI BETS ON AI AGENT
As it transforms itself into a primarily profit-seeking entity, OpenAI is betting big on AI agents, the automated programs that can carry out tasks without human prompting, to jump-start revenue.
Post
DEVELOPERS ARE FIELDING A NEW GENERATION OF AI AGENTS
AI giants including Google, Microsoft, and OpenAI are introducing a new generation of AI “agents” to give businesses another and perhaps more useful reason to embrace generative AI.
Post
CALIFORNIA GOVERNOR VETOES NATION’S MOST STRINGENT AI BILL
California governor Gavin Newsom has vetoed a bill that would have put strong guardrails on AI after the legislature passed the measure by wide margins more than a month ago.
Post
OPENAI COMPLETES FUNDING ROUND VALUING IT AT $157 BILLION
OpenAI has completed a new funding round, raising $6.6 billion in a deal that values the enterprise at $157 billion, nearing double the $86 billion it was valued at early this year.
Post
BACTERIA RESTORE HISTORIC FRESCOES, SCOUR AWAY GRAFFITI
In 2008, Spanish microbiologist Pilar Bosch was wondering what she should research as a subject for her doctoral dissertation when she happened on a study indicating that bacteria could be a useful tool in restoring paintings.
Post
DRUG NOW IN TRIALS RESTORES LOST CONNECTIONS WITHIN THE BRAIN
Human trials are underway for SPG302, a once-daily pill from research-stage startup Spinogenix.
Post
FARM ROBOTS 2.0
Aigen’s bot trundles along between rows of crops, swinging metal arms back and forth under its belly. The arms end in blades, moving at ground height to lop off weeds.
Post
AMERICA IS FALLING APART: OUR NATIONAL PRIORITIES ARE IN DIRE NEED OF RESTRUCTURING
A water main breaks every two minutes somewhere in the U.S., resulting in contaminated drinking supplies and boil water notices.
Post
SYNTHETIC PROGESTERONE LINKED TO INCREASED RISK OF BRAIN CANCER
Synthetic progesterone derivatives, particularly medrogestone, medroxyprogesterone acetate and promegestone, have been linked to a significantly increased risk of intracranial meningiomas, especially with long-term use exceeding one year.